Keywords: protherics, sees, profit, six-month, period, uk-headquartered, biopharmaceutical

Protherics sees profit for six-month period

Article | 20 December 2004

UK-headquartered biopharmaceutical company Protherics, best-known for its snake antivenom agent CroFab (crotalidae polyvalent immune fab-bovine), turned in a profit for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Crofab

Crotalidae Polyvalent Immune Fab Ovine

Antivenin

Crotalidae Polyvalent

methotrexate

Go to drug listing